LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
142,500
+100 (0.07%)
Sep 29, 2025, 3:30 PM KST
45.71%
Market Cap 5.19T
Revenue (ttm) 148.28B
Net Income (ttm) 1.75B
Shares Out 36.41M
EPS (ttm) 47.94
PE Ratio 2,960.11
Forward PE 103.02
Dividend n/a
Ex-Dividend Date n/a
Volume 170,557
Average Volume 375,077
Open 143,400
Previous Close 142,400
Day's Range 140,200 - 143,900
52-Week Range 89,500 - 167,700
Beta 0.85
RSI 42.27
Earnings Date Nov 14, 2025

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.